Britain widens access to Pfizer's Covid antiviral drug through trial

Britain widens access to Pfizer's Covid antiviral drug through trial - Hello loyal readers FeedGoogle, In the article you are reading this time with the title Britain widens access to Pfizer's Covid antiviral drug through trial, We have prepared this article well for you to read and take information in it. hopefully the contents of the post Article World, what we write you can understand. Alright, happy reading.

Paxlovid, a Pfizer's coronavirus disease (Covid-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. — Pfizer handout via Reuters Follow us on Instagram and subscribe to our Telegram channel for the latest updates. LONDON, April 12 ― Britain will expand access to Pfizer's oral antiviral Covid-19 treatment to thousands more people by adding it to a trial to assess how best to use the drug in its highly vaccinated population, the health ministry said today.Paxlovid, a combination of Pfizer's new pill with an older antiviral ritonavir, was made available to thousands of people with compromised immune systems in Britain in February.Now Paxlovid is being added to the Panoramic national study in England, which is making antivirals available to a wide number of patients while collecting data on how the drug…